E. J. Cohn, L. E. Strong, W. L. Hughes, D. J. Mulford, J. N. Ashworth et al., Preparation and Properties of Serum and Plasma Proteins. IV. A System for the Separation into Fractions of the Protein and Lipoprotein Components of Biological Tissues and Fluids 1a,b,c,d, J Am Chem Soc. mars, vol.68, issue.3, pp.459-75, 1946.

O. C. Bruton and . Agammaglobulinemia, Pediatrics. juin, vol.9, issue.6, pp.722-730, 1952.

P. Imbach, S. Barandun, V. Apuzzo, C. Baumgartner, A. Hirt et al., Highdose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood, Lancet Lond Engl. 6 juin, vol.1, issue.8232, pp.1228-1259, 1981.

J. Jost, L. Magy, and V. Ratsimbazafy, Immunoglobulines polyvalentes : évaluation du bon usage, Pharm Hosp Clin. juin, vol.49, issue.2, p.67, 2014.

A. Balch, J. Wilkes, E. Thorell, P. A. Sherwin, C. Enioutina et al., Changing trends in IVIG use in pediatric patients: A retrospective review of practices in a network of major USA pediatric hospitals, Int Immunopharmacol, vol.76, p.105868, 2019.

N. Rezaie, E. Shajareh, M. R. Motamed, B. Ghanbari, N. Pakdaman et al., Intravenous Immunoglobin Utilization Study in a Teaching Hospital, Arch Iran Med. 1 mai, vol.22, issue.5, pp.232-237, 2019.

P. Ortiz-salas, A. Velez-van-meerbeke, C. A. Galvis-gomez, Q. Rodriguez, and . Jh, Human Immunoglobulin Versus Plasmapheresis in Guillain-Barre Syndrome and Myasthenia Gravis: A Meta-Analysis, J Clin Neuromuscul Dis. sept, vol.18, issue.1, pp.1-11, 2016.

R. De-concertation-pluridisciplinaire-igiv and -. __,

R. Médecin-responsable-de-la,

N. De-naissance-;-_______________________]-nom-d'epouse,

, Diagnostic : [_______________________________________________________________________________________________________] Date de diagnostic

, Motif de la concertation :?initiation de traitement ? renouvellement Traitements antérieurs

T. Associés,

, Décision (cf. verso de la fiche)

, Si refus, autre traitement proposé

, Si autorisation, dose préconisée